Biogen Inc. buy Truist Financial Co.
Start price
05.08.24
/
50%
€182.00
Target price
05.08.25
€275.27
Performance (%)
-37.28%
End price
06.08.25
€114.15
Summary
This prediction ended on 06.08.25 with a price of €114.15. The BUY prediction by Truist_Financial_Co_ for Biogen Inc. performed very badly with a performance of -37.28%. Truist_Financial_Co_ has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.015% | -2.015% | 4.219% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $302.00 price target on the stock, down previously from $340.00.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten